No abstract available
Keywords:
HER2; PIK3CA; mTOR; targeted therapy; uterine serous carcinoma.
Publication types
-
Editorial
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antineoplastic Agents / pharmacology
-
Antineoplastic Agents / therapeutic use
-
Cystadenocarcinoma, Serous / drug therapy*
-
Cystadenocarcinoma, Serous / genetics
-
Female
-
Gene Amplification / genetics
-
Humans
-
Molecular Targeted Therapy* / methods
-
Receptor, ErbB-2 / drug effects
-
Receptor, ErbB-2 / genetics
-
Uterine Neoplasms / drug therapy*
-
Uterine Neoplasms / genetics
Substances
-
Antineoplastic Agents
-
ERBB2 protein, human
-
Receptor, ErbB-2